Manila Times Business
DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration
Dalton is a drug discovery platform integrating agentic AI, human expertise, and experimental data, into one continuous learning engineAnnounces collaboration with Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), as a client LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- DaltonTx, the intelligence backbone for modern drug discovery: connecting AI, human expertise and experimental data, today announced the launch of Dalton, its drug discovery platform. Dal
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
TrendAI™ Joins Anthropic's Project Glasswing
Just now
TelkomMetra Strengthens Its Business Portfolio Restructuring Strategy, AdMedika Group Ready for Distinct Expansion under Fullerton Health
Just now
Palace backs Gatchalian as legitimate Senate leader, urges squabbling senators to 'sort it out'
Just now
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
Just now